Of all human breast cancers, ∼25% are associated with amplification and overexpression of ERBB2. In particular, overexpression of ERBB2 drives cell survival, proliferation, motility and the invasion mechanisms characteristic of this aggressive form of human breast cancer (1). The gene discussed is ERBB2; the disease is breast carcinoma.